1.14000 USD
0.024
2.06%
Last update Dec 16, 3:57 PM EST
Main market
Day range
1.14000
1.18000
Previous close
1.16400
Open
1.16300
Access this stock data via API
Subscribe
Interpace Biosciences Inc.
1.14
0.02
2.06%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 8.8M 9.2M 11.5M 12.3M
Cost of revenue 3.3M 4.0M 4.1M 3.4M
Gross profit 5.4M 5.3M 7.4M 8.9M
Operating expense
Research & development 150K 173K 177K 193K
Selling general and admin 4.1M 5.6M 5.4M 5.7M
Other operating expenses
Operating income 1.1M -468K 1.8M 3.1M
Non operating interest income
Income
Expense 30K 49K 78K 111K
Other income expense -115K -16K 21K -93K
Pretax income 1M -533K 1.8M 2.9M
Tax provision -11K 0 18K -8K
Net income 911K -640K 1.6M 2.9M
Basic EPS 0.2 -0.1 0.4
Diluted EPS 0.0 -0.1 0.1
Basic average shares 4.4M 4.4M 4.4M
Diluted average shares 27.7M 4.4M 27.7M
EBITDA 1.2M -285K 2.0M 3.2M
Net income from continuing op. 911K -640K 1.6M 2.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 4 minutes

11:55
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).